Cargando…

Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children

INTRODUCTION: The emergence of multidrug-resistant Pseudomonas aeruginosa poses a global threat, but the distribution and resistance profiling are unclear, especially in young children. Infections due to P. aeruginosa are common, associated with high mortality, and increasingly β-lactam drug resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Sandip, Chen, Xiaowen, Dong, Shaowei, Mai, Huirong, Lopes, Bruno Silvester, Liu, Sixi, Wen, Feiqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244630/
https://www.ncbi.nlm.nih.gov/pubmed/37293207
http://dx.doi.org/10.3389/fcimb.2023.1168096
_version_ 1785054682918420480
author Patil, Sandip
Chen, Xiaowen
Dong, Shaowei
Mai, Huirong
Lopes, Bruno Silvester
Liu, Sixi
Wen, Feiqiu
author_facet Patil, Sandip
Chen, Xiaowen
Dong, Shaowei
Mai, Huirong
Lopes, Bruno Silvester
Liu, Sixi
Wen, Feiqiu
author_sort Patil, Sandip
collection PubMed
description INTRODUCTION: The emergence of multidrug-resistant Pseudomonas aeruginosa poses a global threat, but the distribution and resistance profiling are unclear, especially in young children. Infections due to P. aeruginosa are common, associated with high mortality, and increasingly β-lactam drug resistant. METHODS: We studied the molecular epidemiology and antibiotic resistance mechanisms in 294 clinicalisolates of P. aeruginosa from a pediatric hospital in China. Non-duplicate isolates were recovered from clinical cases and were identified using an API-20 kit followed by antimicrobial susceptibility testing using the VITEK®2 compact system (BioMerieux, France) and also by broth dilution method. In addition, a double-disc synergy test for the ESBL/E-test for MBL was performed. The presence of beta-lactamases, plasmid types, and sequence types was determined by PCR and sequencing. RESULTS: Fifty-six percent (n = 164) of the isolates were resistant to piperacillin–tazobactam, followed by cefepime (40%; n = 117), ceftazidime (39%; n = 115), imipenem (36%; n = 106), meropenem (33%; n = 97), and ciprofloxacin (32%; n = 94). Forty-two percent (n = 126) of the isolates were positive for ESBL according to the double-disc synergy test. The blaCTX-M-15 cephalosporinase was observed in 32% (n = 40/126), while 26% (n = 33/126) werepositive for blaNDM-1 carbapenemase. Aminoglycoside resistance gene aac(3)IIIawas observed in 16% (n = 20/126), and glycylcyclines resistance gene tet(A) was observed in 12% (n = 15/126) of the isolates. A total of 23 sequence types were detected, including ST1963 (12%; n = 16), followed by ST381 (11%; n = 14), ST234 (10%; n = 13), ST145 (58%; n = 10), ST304 (57%; n = 9), ST663 (5%; n = 7), and a novel strain. In ESBL-producing P. aeruginosa, 12 different Incompatibility groups (Inc) were observed, the most common being IncFI, IncFIS, and IncA/C. The MOBP was the most common plasmid type, followed by MOBH, MOBF, and MOBQ. DISCUSSION: Our data suggest that the spread of antibiotic resistance is likely due toclonal spread and dissemination of different clinical strains of P. aeruginosa harbouring different plasmids. This is a growing threat in hospitals particularly in young children which needs robust prevention strategies.
format Online
Article
Text
id pubmed-10244630
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102446302023-06-08 Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children Patil, Sandip Chen, Xiaowen Dong, Shaowei Mai, Huirong Lopes, Bruno Silvester Liu, Sixi Wen, Feiqiu Front Cell Infect Microbiol Cellular and Infection Microbiology INTRODUCTION: The emergence of multidrug-resistant Pseudomonas aeruginosa poses a global threat, but the distribution and resistance profiling are unclear, especially in young children. Infections due to P. aeruginosa are common, associated with high mortality, and increasingly β-lactam drug resistant. METHODS: We studied the molecular epidemiology and antibiotic resistance mechanisms in 294 clinicalisolates of P. aeruginosa from a pediatric hospital in China. Non-duplicate isolates were recovered from clinical cases and were identified using an API-20 kit followed by antimicrobial susceptibility testing using the VITEK®2 compact system (BioMerieux, France) and also by broth dilution method. In addition, a double-disc synergy test for the ESBL/E-test for MBL was performed. The presence of beta-lactamases, plasmid types, and sequence types was determined by PCR and sequencing. RESULTS: Fifty-six percent (n = 164) of the isolates were resistant to piperacillin–tazobactam, followed by cefepime (40%; n = 117), ceftazidime (39%; n = 115), imipenem (36%; n = 106), meropenem (33%; n = 97), and ciprofloxacin (32%; n = 94). Forty-two percent (n = 126) of the isolates were positive for ESBL according to the double-disc synergy test. The blaCTX-M-15 cephalosporinase was observed in 32% (n = 40/126), while 26% (n = 33/126) werepositive for blaNDM-1 carbapenemase. Aminoglycoside resistance gene aac(3)IIIawas observed in 16% (n = 20/126), and glycylcyclines resistance gene tet(A) was observed in 12% (n = 15/126) of the isolates. A total of 23 sequence types were detected, including ST1963 (12%; n = 16), followed by ST381 (11%; n = 14), ST234 (10%; n = 13), ST145 (58%; n = 10), ST304 (57%; n = 9), ST663 (5%; n = 7), and a novel strain. In ESBL-producing P. aeruginosa, 12 different Incompatibility groups (Inc) were observed, the most common being IncFI, IncFIS, and IncA/C. The MOBP was the most common plasmid type, followed by MOBH, MOBF, and MOBQ. DISCUSSION: Our data suggest that the spread of antibiotic resistance is likely due toclonal spread and dissemination of different clinical strains of P. aeruginosa harbouring different plasmids. This is a growing threat in hospitals particularly in young children which needs robust prevention strategies. Frontiers Media S.A. 2023-05-24 /pmc/articles/PMC10244630/ /pubmed/37293207 http://dx.doi.org/10.3389/fcimb.2023.1168096 Text en Copyright © 2023 Patil, Chen, Dong, Mai, Lopes, Liu and Wen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Patil, Sandip
Chen, Xiaowen
Dong, Shaowei
Mai, Huirong
Lopes, Bruno Silvester
Liu, Sixi
Wen, Feiqiu
Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
title Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
title_full Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
title_fullStr Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
title_full_unstemmed Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
title_short Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing Pseudomonas aeruginosa in young children
title_sort resistance genomics and molecular epidemiology of high-risk clones of esbl-producing pseudomonas aeruginosa in young children
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244630/
https://www.ncbi.nlm.nih.gov/pubmed/37293207
http://dx.doi.org/10.3389/fcimb.2023.1168096
work_keys_str_mv AT patilsandip resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren
AT chenxiaowen resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren
AT dongshaowei resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren
AT maihuirong resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren
AT lopesbrunosilvester resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren
AT liusixi resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren
AT wenfeiqiu resistancegenomicsandmolecularepidemiologyofhighriskclonesofesblproducingpseudomonasaeruginosainyoungchildren